Virtual NIH Meeting Decides Tuberculosis Research Grant Winners
Published Date: 3/24/2025
Notice
Summary
The National Institute of Allergy and Infectious Diseases is holding a closed meeting on April 28, 2025, to review grant applications focused on stopping tuberculosis. This meeting affects researchers applying for funding and keeps sensitive info private. No public attendance or money changes are involved, but it’s a key step in deciding who gets research support.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Closed NIH Grant Review for TB R01
If you submitted a grant application for the NIAID "Halting Tuberculosis (R01 Clinical Trial Optional)" program, your application will be reviewed and evaluated at a closed meeting on April 28, 2025, from 9:00 a.m. to 6:00 p.m. The meeting is closed to the public under 5 U.S.C. 552b(c)(4) and 552b(c)(6) because discussions could disclose confidential trade secrets, patentable material, or personal information; the meeting will be video-assisted and held at 5601 Fishers Lane, Room 3F58, Rockville, MD.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-11892 — Proposed Collection; 60-Day Comment Request; Specimen Resource Locator (National Cancer Institute)
The National Cancer Institute wants your thoughts on a new way to track and locate cancer research samples through their Specimen Resource Locator. This affects researchers and labs who use these samples, aiming to make finding and sharing easier without adding extra costs or delays. You’ve got 60 days to share your feedback and help shape this helpful tool!
2026-11390 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding to advance science. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-11367 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review at the NIH is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide who gets funding for exciting science projects. If you’re involved in cell biology, heart disease, mental health, or cancer research, these reviews could impact your funding timeline and opportunities.
2026-11357 — National Library of Medicine; Notice of Partially Closed Meeting
The National Library of Medicine’s Board of Regents will hold a virtual meeting on July 16, 2026, with some parts open to the public and others closed to protect private info and trade secrets. This meeting affects researchers and grant applicants, as grant reviews will happen behind closed doors. Anyone can watch the open sessions online and send comments up to 15 days before the meeting—no registration needed!
2026-11018 — Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review is holding several closed virtual meetings in late June and early July 2026 to review important grant applications. These meetings protect private info and trade secrets while deciding which scientific projects get funding. Researchers applying for grants should note these dates as they impact funding decisions but don’t involve public attendance or extra costs.
2026-10813 — Government-Owned Inventions; Availability for Licensing
The National Institutes of Health just announced a cool new antibody called 18H2 that helps scientists spot a key protein in immune cells that keep us healthy. This invention is ready for companies to license and turn into real products, speeding up research and treatments for autoimmune diseases. If you’re interested, now’s the time to reach out and get the details—money and timing depend on your licensing deal!
Previous / Next Documents
Previous: 2025-04950 — Mack Trucks LLC, Receipt of Petition for Decision of Inconsequential Noncompliance
Mack Trucks found that some 2017-2026 Pinnacle and 2017-2019 CHU trucks don’t fully meet air brake safety rules. They told the government and asked for a pass, saying the issue won’t hurt safety. This means owners and drivers might not see any changes or costs while the decision is being made.
Next: 2025-04953 — National Library of Medicine; Notice of Closed Meeting
The National Library of Medicine’s Board of Regents will hold a virtual meeting on May 13, 2025, to discuss programs and review grant applications. Part of the meeting will be closed to protect private info and trade secrets. Anyone can watch the open session online and send written comments up to 15 days before the meeting.